DynHeter-DTA: Dynamic Heterogeneous Graph Representation for Drug-Target Binding Affinity Prediction
Open Access
- 30 January 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (3) , 1223
Abstract
In drug development, drug-target affinity (DTA) prediction is a key indicator for assessing the drug’s efficacy and safety. Despite significant progress in deep learning-based affinity prediction approaches in recent years, there are still limitations in capturing the complex interactions between drugs and target receptors. To address this issue, a dynamic heterogeneous graph prediction model, DynHeter-DTA, is proposed in this paper, which fully leverages the complex relationships between drug–drug, protein–protein, and drug–protein interactions, allowing the model to adaptively learn the optimal graph structures. Specifically, (1) in the data processing layer, to better utilize the similarities and interactions between drugs and proteins, the model dynamically adjusts the connection strengths between drug–drug, protein–protein, and drug–protein pairs, constructing a variable heterogeneous graph structure, which significantly improves the model’s expressive power and generalization performance; (2) in the model design layer, considering that the quantity of protein nodes significantly exceeds that of drug nodes, an approach leveraging Graph Isomorphism Networks (GIN) and Self-Attention Graph Pooling (SAGPooling) is proposed to enhance prediction efficiency and accuracy. Comprehensive experiments on the Davis, KIBA, and Human public datasets demonstrate that DynHeter-DTA exceeds the performance of previous models in drug-target interaction forecasting, providing an innovative solution for drug-target affinity prediction.Keywords
This publication has 43 references indexed in Scilit:
- Decision tree classifier based on topological characteristics of subgraph for the mining of protein complexes from large scale PPI networksComputational Biology and Chemistry, 2023
- A survey of drug-target interaction and affinity prediction methods via graph neural networksComputers in Biology and Medicine, 2023
- GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual informationComputers in Biology and Medicine, 2022
- Hierarchical graph representation learning for the prediction of drug-target binding affinityInformation Sciences, 2022
- Molecular generative Graph Neural Networks for Drug DiscoveryNeurocomputing, 2021
- GanDTI: A multi-task neural network for drug-target interaction predictionComputational Biology and Chemistry, 2021
- Graph neural networks for automated de novo drug designDrug Discovery Today, 2021
- Deep learning in drug discovery: opportunities, challenges and future prospectsDrug Discovery Today, 2019
- Progress in molecular dockingQuantitative Biology, 2019
- Deep Learning in Drug DiscoveryMolecular Informatics, 2015